A prospective observational study of ultra-hypofractionated radiotherapy for postoperative breast cancer patients

UMIN ID: UMIN000054077

Registered date:05/04/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Breast cancer
• Date of first enrollment: 2024/05/01
• Target sample size: 30
• Countries of recruitment: Japan
• Study type: Observational

Outcome(s)

• Primary Outcome: Adverse events at 1, 3, and 6 months after the start of radiation therapy

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: Not applicable
• Gender: Female
• Exclude criteria: Patients with infections that require systemic treatment. Pregnant, possibly pregnant, or lactating patients. Patients who have previously received chest radiation therapy. Patients are scheduled for concurrent chemotherapy. Patients with diabetes mellitus who are being treated with continuous insulin injections or are poorly controlled. Patients diagnosed with interstitial pneumonia, pulmonary fibrosis, or severe emphysema. Patients receive continuous systemic administration (oral or intravenous) of steroids. Patients receiving immunosuppressive agents for active collagen disease Patients with severe cardiac disease or heart failure. Patients who are deemed ineligible for participation in this study by the principal investigator or principal investigator-designated physicians.

Related Information

• Primary Sponsor: Juntendo University
• Source(s) of Monetary Support: None